EdgarLookup

Baranick Brian

Insider transactions at 1 company

This page shows all SEC Form 4 filings attributed to Baranick Brian. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

EXAS
Company Title Type Shares Price Value Date
EXAS EVP, GM, Precision Oncology Option Exercise 3,955 Dec 23, 2025
EXAS EVP, GM, Precision Oncology Sale 2,858 $70.08 $200,289 Nov 4, 2025
EXAS EVP, GM, Precision Oncology Tax Withholding 2,717 $46.83 $127,237 Aug 5, 2025
EXAS EVP, GM, Precision Oncology Tax Withholding 2,513 $47.82 $120,172 Feb 28, 2025
EXAS EVP, GM, Precision Oncology Tax Withholding 2,008 $51.28 $102,970 Feb 25, 2025
EXAS EVP, GM, Precision Oncology Tax Withholding 968 $49.63 $48,042 Feb 19, 2025
EXAS EVP, GM, Precision Oncology Sale 929 $70.00 $65,030 Oct 8, 2024
EXAS EVP, GM, Precision Oncology Sale 929 $70.00 $65,030 Sep 18, 2024
EXAS EVP, GM, Precision Oncology Tax Withholding 1,375 $55.77 $76,684 Aug 5, 2024
EXAS EVP, GM., Precision Oncology Sale 110 $60.15 $6,617 Apr 30, 2024
EXAS EVP, GM., Precision Oncology Sale 924 $79.43 $73,393 Apr 2, 2024
EXAS Gen. Mgr., Precision Oncology Option Exercise 4,724 Mar 1, 2024
EXAS Gen. Mgr., Precision Oncology Sale 2,027 $56.89 $115,316 Feb 26, 2024
EXAS Gen. Mgr., Precision Oncology Option Exercise 1,729 Feb 21, 2024
EXAS Gen. Mgr., Precision Oncology Sale 1,093 $59.78 $65,340 Feb 21, 2024
EXAS Gen. Mgr., Precision Oncology Sale 879 $73.50 $64,607 Jan 2, 2024
EXAS Gen. Mgr., Precision Oncology Sale 1,350 $85.04 $114,804 Aug 4, 2023
EXAS Gen. Mgr., Precision Oncology Option Exercise 3,954 Feb 28, 2023
EXAS Gen. Mgr., Precision Oncology Option Exercise 1,729 Feb 22, 2023
EXAS Gen. Mgr., Precision Oncology Sale 984 $47.12 $46,366 Aug 4, 2022